Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(50.0%)
N/A
1(25.0%)
Early Phase 1
1(25.0%)
4Total
Phase 1(2)
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06434935Early Phase 1Enrolling By Invitation

Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit

Role: lead

NCT07078370Not ApplicableEnrolling By Invitation

Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass

Role: lead

NCT05567757Phase 1Completed

Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)

Role: lead

NCT04905511Phase 1Completed

Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)

Role: lead

All 4 trials loaded